Balambao, Maylene .

HRN: 28-77-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/04/2026
05/05/2026
IV
500mg
Q8h
S/P CS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines